Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Receptor selectivity assay Receptor selectivity was evaluated by comparing the ability of compounds to activate related incretin receptors
Guo Z, Yan M, Chen L, Fang P, Li Z, Wan Z, et al
It is generally safe
1000 mg/day, P.O for 12 weeks) in patients with CHD [189, 190]
Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well
US$ 22.94
US$ 24.44
US$ 28.89
US$ 25.93
